| Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions L Ponnusamy, SR Natarajan, K Thangaraj, R Manoharan Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (1), 188379, 2020 | 58 | 2020 |
| MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway SR Natarajan, L Ponnusamy, R Manoharan Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1869 (7), 119242, 2022 | 28 | 2022 |
| MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies K Thangaraj, L Ponnusamy, SR Natarajan, R Manoharan Drug Discovery Today 25 (12), 2161-2173, 2020 | 22 | 2020 |
| MARK2 potentiate aerobic glycolysis‐mediated cell growth in breast cancer through regulating mTOR/HIF‐1α and p53 pathways L Ponnusamy, SR Natarajan, R Manoharan Journal of Cellular Biochemistry 123 (4), 759-771, 2022 | 14 | 2022 |
| Diosgenin derivatives developed from Pd (II) catalysed dehydrogenative coupling exert an effect on breast cancer cells by abrogating their growth and facilitating apoptosis via … S Dharani, G Kalaiarasi, M Ravi, NS Raj, VM Lynch, R Prabhakaran Dalton Transactions 51 (17), 6766-6777, 2022 | 3 | 2022 |
Dr. Selvaraj JayaramanProfessor, Saveetha Dental College & Hospitals, Saveetha Institute of Medical andVerified email at saveetha.com